Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07646314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis Syndrome

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Oct 10, 2026 → Nov 10, 2026
See other at-risk trials from Riphah International University

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 6 more changesShow less
    • Primary completion pushed from Oct 10, 2026 to Nov 10, 2026
    • Study completion date: Nov 20, 2026 to Nov 30, 2026
    • Start date changed from estimate of Jun 17, 2026 to Aug 1, 2026
    • Eligibility criteria expanded, about 13 words
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Piriformis Syndrome (PS) is a condition which is characterized by pain, numbness, and limited range of motion (ROM) due to compression or irritation of the sciatic nerve by the piriformis muscle. It often leads to discomfort in the buttock region, radiating pain along the posterior thigh, and functional limitations in daily activities. Manual therapy techniques, particularly Muscle Energy Techniques (METs), have been widely used for the management of musculoskeletal dysfunctions, including piriformis syndrome.
Trial Details
NCT Number NCT07646314
Lead Sponsor Riphah International University
Conditions
(from sponsor)		 Piriformis Syndrome
Related terms Pain, Piriformis Muscle Syndrome
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov